Papillomavirus humain : dépistage des cancers du col et de l’anus [Human Papillomavirus: screening of cervical and anal cancers]
Fiche du document
19 octobre 2022
- doi: 10.53738/REVMED.2022.18.800.1950
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.800.1950
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36259700
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8C0939C536177
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-04-19 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Papillomaviridae Infectious human wart virus Human wart virus Human papilloma virus Papillomavirus HPV (Virus) Wart virus Papovaviruses Papilloma virusesCiter ce document
B. Pache et al., « Papillomavirus humain : dépistage des cancers du col et de l’anus [Human Papillomavirus: screening of cervical and anal cancers] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.800.1950
Métriques
Partage / Export
Résumé
Cervical cancer is preventable through primary and secondary prevention. Vaccination against the human papillomavirus (HPV), the virus necessary for the development of precancerous lesions, can prevent most of them. Screening by cytology for these precancerous (or cancerous) lesions can be replaced by screening for certain types of HPV, high risk (HR-HPV), causing cervical cancer. The presence of HR-HPV on the cervix should raise suspicion of concomitant infection in the anus, as both epithelia are highly susceptible. This attitude is dictated by the increase incidence in anal cancer in the population, which is also HPV-dependent and therefore also potentially preventable through vaccination and screening.